Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Anesthesia and Analgesia

Volume  6, Issue 6, November-December 2019, Pages 2077-2082
 

Original Article

A Randomised Controlled Study Evaluating the Efficacy of Dexamethasone in Preventing Post-operative Nausea and Vomiting and its Effect on Blood Glucose

Brijesh GC1, Naveen Kumar Chekka2, Shailesh Kumar3, Jay Prakash4, Bijaya Kumar Sethi5, J Prashanth Prabhu6

1Associate Professor, Dept. of Anesthesia and Critical Care Medicine, Sri Muthu Kumaran Medical College Hospital and Research Institute, Chennai, Tamil Nadu 600069, India. 2Consultant Anesthetist, Apollo Cradle Maternity & Children's Hospital, Bangalore, Karnataka 560037, India. 3Assistant Professor, Department of Anesthesiology and Critical Care Medicine, MVJ Medical College and Research Hospital, Hoskote, Karnataka 562114, India. 4,6Assistant Professor, Department of Anaesthesiology

Choose an option to locate / access this Article:
60 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.6619.31

Abstract

Context: Persistent vomiting leads to poor patient satisfaction, delayed wound healing, dehydration and electrolyte disturbances. In addition, vomiting or retching can sometimes result in more serious complications like aspiration, wound dehiscence, increased intracranial pressure, oesophageal rupture and pneumothorax. The expanding number of procedures performed as daycare surgeries has led to the increasing use of dexamethasone for PONV. Aims: The present study is to evaluate the optimum dose of dexamethasone for prevention of PONV and to measure the extent of the hyperglycemic side effects post-operatively in non-diabetics. Settings and Design: Prospective randomized controlled comparative study. Methods and Materials: After approval from the Institutional Ethics Committee, study was conducted on 135 patients of the American Society of Anesthesiologists (ASA) Grade I, II and III, aged between 20 to 60 years and included both genders that underwent elective surgeries under general anesthesia. Patients were randomized into 3 Groups to assess the efficacy of different doses of dexamethasone for prevention of PONV. All post-operative cases were followed up at 0, 12 and 24 hours, PONV and blood sugar levels were measured. PONV was being evaluated on a five-point ordinal scale. Statistical analysis used: Percentage analysis was used for categorical variables and the mean and SD was used for continuous variables. ANOVA with Tukey's Post-hoc test was used for the significant difference and for the repeated measures of ANOVA was used with Bonferroni correction to control the Type I error on multiple comparisons. The collected data were analysed with IBM® SPSS statistics software 23.0 Version. Results: Among categorical variables, p values for age (p - 0.611), gender (p - 0.533), ASA status (p - 0.234) with Chi-square testing were not significant. It is interesting to note that only 1 (2.2%) patient had nausea and vomiting in Group C compared to 5 (11.1%) in Group A and 3 (6.7%) in Group B in the immediate post-operative period. Post-operative blood glucose levels varied significantly in different Groups. In Group A blood sugar levels were 106.93 ± 14.426 mg/dl, Group B 117.31 ± 11.791 mg/dl and Group C 129.49 ± 16.170 mg/dl respectively in the immediate post-operative period. Conclusions: The benefits of administering higher doses of IV Dexamethasone should be weighed against the potential side-effects of short-lasting hyperglycemia.


Keywords : Dexamethasone; PONV; Blood glucose; Antiemetics.
Corresponding Author : Shailesh Kumar